Open AccessP0261 / #2147: MANAGEMENT OF DRUG REFRACTORY ARRHYTHMIA TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SECONDARY TO COVID-19 INFECTION
Author(s) -
María Hernández,
M. Aguilar,
C.D. Mendez Adame,
J. Salinas Selaya,
Olivia Reyes
Publication year - 2021
Publication title -
pediatric critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.299
H-Index - 87
eISSN - 1947-3893
pISSN - 1529-7535
DOI - 10.1097/01.pcc.0000739384.58556.92
Subject(s) - medicine , amiodarone , extracorporeal membrane oxygenation , cardiogenic shock , levosimendan , cardioversion , myocarditis , anesthesia , ventricular tachycardia , esmolol , lidocaine , cardiology , milrinone , hemodynamics , heart failure , atrial fibrillation , myocardial infarction , heart rate , blood pressure
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom